Type I Interferons Control Proliferation and Function of the Intestinal Epithelium

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Wnt pathway activation drives intestinal epithelial proliferation, requiring tight regulation to prevent cancer and barrier dysfunction.
• Type I interferons (IFN), influenced by gut microbiota, possess antiproliferative effects, but their role in intestinal epithelial renewal remains unclear.

Purpose of the Study:

• To investigate the role of type I interferons (IFN) in regulating intestinal epithelial cell renewal.
• To elucidate the function of casein kinase 1α (CK1α) in controlling intestinal epithelial homeostasis and its interplay with IFN signaling.

Main Methods:

• Intestinal knockout models of casein kinase 1α (CK1α) and IFNAR1.
• Analysis of β-catenin and IFN pathway activation, p53 pathway signaling, apoptosis, and senescence markers.
• Assessment of intestinal barrier function and epithelial cell proliferation.

Main Results:

• CK1α ablation activates both β-catenin and IFN pathways, preventing unlimited intestinal epithelial proliferation despite constitutive β-catenin activity.
• IFN signaling mediates p53 pathway activation, inducing apoptosis and senescence markers in CK1α-deficient guts.
• Concurrent ablation of CK1α and IFNAR1 results in intestinal hyperplasia, reduced apoptosis, and rapid, lethal barrier dysfunction.

Conclusions:

• Type I interferons (IFN) play a critical role in controlling intestinal epithelial proliferation and function, particularly under conditions of β-catenin activation.
• IFN signaling acts as a crucial brake on Wnt-driven proliferation, maintaining intestinal homeostasis and barrier integrity.